Display screen or portion thereof with graphical user interface for patient information for multidisciplinary cancer treatment planning

Burnell , et al. November 17, 2

Patent Grant D902227

U.S. patent number D902,227 [Application Number D/615,907] was granted by the patent office on 2020-11-17 for display screen or portion thereof with graphical user interface for patient information for multidisciplinary cancer treatment planning. This patent grant is currently assigned to Roche Molecular Systems, Inc.. The grantee listed for this patent is Roche Molecular Systems, Inc.. Invention is credited to Dania Maria Afonso, Michael Barnes, Stephen Burnell, Rita Isabel da Silva Reis, Namita Deshpande, William Evans, Leia Garrote-Gallego, Alex Kalogrides, Weng Chi Lou, Joao Paulo Alves Mendes, Vikram Mohan, Mark M. Morita, Oluwatosin Oyeniran, Michael Pan, Chandana Pandrangi, Margaret Ann Peterson, Amelia E. Schladow, Joachim Schmid, Dominik Seeger, Eduardo Ferrao Ulrich.


United States Patent D902,227
Burnell ,   et al. November 17, 2020

Display screen or portion thereof with graphical user interface for patient information for multidisciplinary cancer treatment planning

Claims

CLAIM The ornamental design for a display screen or portion thereof with graphical user interface for patient information for multidisciplinary cancer treatment planning, as shown and described.
Inventors: Burnell; Stephen (Santa Cruz, CA), Schmid; Joachim (Tucson, AZ), Mohan; Vikram (Tucson, AZ), Barnes; Michael (San Francisco, CA), Evans; William (Mountain View, CA), Oyeniran; Oluwatosin (San Jose, CA), Garrote-Gallego; Leia (Madrid, ES), Morita; Mark M. (Morgan Hill, CA), Pan; Michael (Tucson, AZ), Kalogrides; Alex (Tucson, AZ), Pandrangi; Chandana (Tucson, AZ), da Silva Reis; Rita Isabel (Lisbon, PT), Mendes; Joao Paulo Alves (Lisbon, PT), Peterson; Margaret Ann (Tucson, AZ), Deshpande; Namita (Tucson, AZ), Schladow; Amelia E. (Tucson, AZ), Lou; Weng Chi (Tucson, AZ), Seeger; Dominik (Berlin, DE), Afonso; Dania Maria (Lisbon, PT), Ulrich; Eduardo Ferrao (Lisbon, PT)
Applicant:
Name City State Country Type

Roche Molecular Systems, Inc.

Pleasanton

CA

US
Assignee: Roche Molecular Systems, Inc. (Pleasanton, CA)
Appl. No.: D/615,907
Filed: August 31, 2017

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
15263236 Sep 12, 2016

Current U.S. Class: D14/486
Current International Class: 1404
Field of Search: ;D14/485,486

References Cited [Referenced By]

U.S. Patent Documents
D682853 May 2013 Walsh
D689072 September 2013 Park
D710869 August 2014 Davis
D770484 November 2016 Kenna
D820288 June 2018 Howell
2017/0212668 July 2017 Shah
2019/0342185 November 2019 Barmentloo
Primary Examiner: Shelton; Richelle G
Attorney, Agent or Firm: Kilpatrick Townsend & Stockton LLP

Description



The FIGURE is a front view of a display screen or portion thereof with graphical user interface for patient information for multidisciplinary cancer treatment planning showing our new design.

The broken lines in the drawing showing the display screen or portion thereof and the remainder of the graphical user interface form no part of the claimed design.

* * * * *

Patent Diagrams and Documents

D00000


D00001


XML


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed